Our Pricing

Mysimba vs Mounjaro Weight Loss UK: Clinical Comparison

Published on: June 03, 2026

Choosing between mysimba vs mounjaro weight loss UK treatments requires understanding how each medication works and which suits your clinical profile. At Cured Pharmacy, our UK-registered prescribers assess your medical history to recommend the most appropriate option, whether that's the dual-action tablet Mysimba or the once-weekly injectable Mounjaro.

How Mysimba and Mounjaro Work Differently

Mysimba contains naltrexone 8mg and bupropion 90mg, two active ingredients that work on the central nervous system to reduce appetite and food cravings [1]. This oral tablet targets the brain's reward pathways and hunger centres, making it easier to adhere to reduced-calorie diets without the need for injections.

Mounjaro (tirzepatide) is the UK's first dual GIP/GLP-1 receptor agonist, administered as a once-weekly subcutaneous injection [2]. It mimics two naturally occurring hormones that regulate blood sugar, slow gastric emptying, and enhance satiety signals. In the SURPASS-1 trial, participants achieved up to 22.5% body weight reduction over 72 weeks at the highest dose [2].

The fundamental difference lies in their mechanisms: Mysimba modifies neurological appetite signals through oral administration, whilst Mounjaro activates hormonal pathways via injection. Both require prescription and clinical assessment by a UK prescriber before dispensing.

Mysimba vs Mounjaro Weight Loss Results

Clinical trial data shows distinct efficacy profiles for each treatment. In the COR-I trial, Mysimba users lost an average of 8.1% body weight over 56 weeks when combined with diet and exercise [1]. Responders—those who lost at least 5% body weight by week 16—achieved significantly greater reductions, with many reaching 10-12% total weight loss.

Mounjaro demonstrates higher average weight loss in clinical trials. The SURMOUNT-1 study reported mean reductions of 15% to 20.9% depending on dose, with the 15mg weekly injection producing the greatest effect [3]. These results surpass those seen with single-pathway GLP-1 medications like semaglutide.

Individual response varies considerably. Some patients respond better to neurological appetite suppression with Mysimba, whilst others achieve superior results with hormonal regulation via Mounjaro. Your UK prescriber will consider your BMI, medical history, previous weight loss attempts, and tolerance for injections when recommending treatment.

Factors Influencing Treatment Choice

Patients with needle phobia or preference for oral medication may favour Mysimba tablets taken twice daily. Those seeking maximum weight loss potential or who have struggled with previous oral treatments might benefit more from Mounjaro injections. Medical contraindications also play a role—Mysimba is unsuitable for patients with uncontrolled hypertension or seizure disorders, whilst Mounjaro requires caution in those with diabetic retinopathy or pancreatitis history [1][2].

Side Effects: Mysimba vs Mounjaro Comparison

Mysimba's most common side effects include nausea (affecting up to 30% of users initially), constipation, headache, dizziness, and insomnia [1]. These typically diminish after the first month as the body adjusts to the medication. The dose is gradually increased over four weeks to minimise gastrointestinal discomfort. Serious but rare risks include seizures and elevated blood pressure, which is why regular monitoring is required.

Mounjaro users frequently experience gastrointestinal effects, particularly nausea (12-22% depending on dose), vomiting, diarrhoea, and constipation [2]. These side effects are usually mild to moderate and decrease over time. More serious but uncommon risks include pancreatitis, gallbladder disease, and thyroid tumours (observed in animal studies). Injection site reactions such as redness or itching affect approximately 2% of patients.

Both medications require clinical supervision throughout treatment. At Cured Pharmacy, our UK prescribers review your progress and side effect profile during follow-up consultations, adjusting treatment plans as needed to optimise outcomes whilst minimising adverse effects.

Managing Common Side Effects

For Mysimba users experiencing nausea, taking tablets with food and staying well-hydrated can help. The gradual dose escalation protocol exists specifically to improve tolerability. Mounjaro patients should inject on the same day each week and may find nausea lessens by avoiding large, fatty meals. If side effects persist beyond the first month or become severe, contact your prescriber—dose adjustment or treatment change may be appropriate.

Dosing and Administration: Practical Considerations

Mysimba requires twice-daily oral administration, starting with one tablet each morning for week one, then increasing gradually to the maintenance dose of two tablets twice daily by week four [1]. This titration schedule helps minimise side effects. Tablets should be swallowed whole with water and can be taken with or without food. Missing doses can reduce efficacy, so establishing a consistent routine is important.

Mounjaro is administered as a single subcutaneous injection once weekly, on the same day each week. Treatment begins at 2.5mg for four weeks, then increases to 5mg. Your prescriber may further increase the dose every four weeks based on response and tolerability, up to a maximum of 15mg weekly [2]. The pre-filled KwikPen is designed for self-administration into the abdomen, thigh, or upper arm.

The practical difference is significant: Mysimba demands daily commitment and consistency, whilst Mounjaro requires only weekly injections but involves needle use and proper storage (refrigeration until first use). At Cured Pharmacy, we provide detailed administration guidance and support for whichever treatment your UK prescriber recommends.

Cost Comparison and Treatment Duration

Mysimba is available at Cured Pharmacy from £135.00 for a one-month supply. Treatment duration varies—NICE guidance suggests discontinuing if patients haven't lost at least 5% body weight after 16 weeks, or 10% after one year [4]. Many patients continue for 6-12 months to achieve and consolidate their weight loss goals.

Mounjaro starts from £124.99 at Cured Pharmacy, with pricing dependent on your prescribed dose. Clinical trials evaluated treatment over 72 weeks, though some patients may require longer or shorter courses based on individual response. Both medications are intended for long-term weight management alongside lifestyle modifications, not short-term fixes.

When comparing costs, consider the total treatment journey including consultation fees, monitoring requirements, and potential dose adjustments. Cured Pharmacy offers transparent upfront pricing with no hidden charges—you'll see the exact cost before completing your free online consultation with a UK prescriber.

Value Beyond Price

The most cost-effective treatment isn't always the cheapest—it's the one that works best for your body and circumstances. Some patients achieve excellent results with the more affordable option, whilst others require the higher-efficacy treatment to reach their health goals. Your UK prescriber will help balance clinical suitability, efficacy expectations, and budget considerations when recommending between Mysimba and Mounjaro.

Who Should Choose Mysimba vs Mounjaro?

Mysimba may be more suitable for patients who prefer oral medication, have needle phobia, or have struggled with previous weight loss attempts using diet and exercise alone. It's licensed for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities such as hypertension or type 2 diabetes [1]. Patients must be willing to commit to twice-daily dosing and gradual dose escalation.

Mounjaro is often recommended for patients seeking maximum weight loss efficacy, those comfortable with weekly injections, or individuals who haven't responded adequately to other weight management treatments. It's particularly effective for patients with type 2 diabetes due to its glucose-lowering properties, though it's also licensed for weight management in non-diabetic patients [2]. The once-weekly schedule suits those who struggle with daily medication adherence.

Contraindications differ between treatments. Mysimba cannot be used by patients taking opioid medications, MAOIs, or those with seizure disorders, eating disorders, or uncontrolled hypertension [1]. Mounjaro requires caution in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [2]. Your UK prescriber at Cured Pharmacy will review your complete medical history to determine which treatment—if any—is clinically appropriate for you.

Scientific References

1. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss medications are most effective when combined with a reduced-calorie diet and increased physical activity.